The quantitative analysis revealed that in non-pathological age-matched controls approximately half of the Iba1+ population was positive for 5-Lox immunoreactivity (Fig. 2e), while in AD samples about 2/3 of the microglia were 5-Lox positive (Fig. 2f). This evidence concerns the gene AIF1 and Alzheimer disease.